A phase IA, dose-escalating study of LBH589 administered intravenously in adult patients with advanced solid tumors

被引：0
|
作者：
Oizumi, S. [1 ]
Ando, Y. [2 ]
Kitagawa, K. [2 ]
Morita, S. [2 ]
Komatsu, Y. [3 ]
Yuki, S. [3 ]
Fujiwara, Y. [4 ,5 ]
Kiyota, N. [4 ,5 ]
Kobayashi, K. [6 ]
Minami, H. [4 ,5 ]
机构：
[1] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan
[2] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan
[4] Kobe Univ Hosp, Kobe, Hyogo, Japan
[5] Grad Sch Med, Dept Med, Kobe, Hyogo, Japan
[6] Novartis Pharma KK, Oncol Translat Med, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72099-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [21] QT Interval Measurements in Patients with Hematologic Malignancies and Solid Tumors Treated with Oral Panobinostat (LBH589)
    Weber, Harald A.
    Tai, Feng
    Paul, Sofia
    Schindler, Joanne
    Woo, Margaret M.
    Spence, Stan
    Marlowe, Jennifer
    Lin, Rong
    BLOOD, 2009, 114 (22) : 1454 - 1454
  • [22] Results of cardiac monitoring during phase I trials of a novel histone deacetylase (HDAC) inhibitor LBH589 in patients with advanced solid tumors and hematologic malignancies
    Fischer, T
    Patnaik, A
    Bhalla, K
    Beck, J
    Morganroth, J
    Laird, GH
    Sharma, S
    Scott, JW
    Dugan, M
    Giles, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 218S - 218S
  • [23] A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
    Vilar, Eduardo
    Gruenwald, Viktor
    Schoeffski, Patrick
    Singer, Harald
    Salazar, Ramon
    Luis Iglesias, Jose
    Casado, Esther
    Cullell-Young, Martin
    Baselga, Jose
    Tabernero, Josep
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 299 - 305
  • [24] A Phase IA, Open-label, Dose-escalating Study of PTK787/ZK 222584 Administered Orally on a Continuous Dosing Schedule in Patients with Advanced Cancer
    Drevs, Joachim
    Medinger, Michael
    Mross, Klaus
    Fuxius, Stefan
    Hennig, Juergen
    Buechert, Martin
    Thomas, Anne
    Unger, Clemens
    Chen, Bee-Lian
    Lebwohl, David
    Laurent, Dirk
    ANTICANCER RESEARCH, 2010, 30 (06) : 2335 - 2339
  • [25] A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
    Eduardo Vilar
    Viktor Grünwald
    Patrick Schöffski
    Harald Singer
    Ramon Salazar
    Jose Luis Iglesias
    Esther Casado
    Martin Cullell-Young
    Jose Baselga
    Josep Tabernero
    Investigational New Drugs, 2012, 30 : 299 - 305
  • [26] Phase I, open-label, dose-escalating clinical and pharmacokinetic study of PM00104 administered weekly resting every fourth week, intravenously, over 1 hour to patients with advanced malignant solid tumors or lymphoma
    Plummer, Ruth
    Coronado, C.
    Massard, Christophe
    Calvert, A. H.
    Margetts, J.
    Bahleda, Rastilav
    Prados, R.
    Kahatt, C.
    Soria, Jean-Charles
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors
    Gonçalves, A
    Viret, F
    Ciccolini, J
    Genre, D
    Gravis, G
    Giovanini, M
    Camerlo, J
    Catalin, J
    Maraninchi, D
    Viens, P
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 102 - 108
  • [28] Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Weiss, J
    Ferrier, A
    Vukovic, V
    Weitman, S
    Richards, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 223S - 223S
  • [29] Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
    Tan, Winston W.
    Allred, Jacob B.
    Moreno-Aspitia, Alvaro
    Northfelt, Donald W.
    Ingle, James N.
    Goetz, Matthew P.
    Perez, Edith A.
    CLINICAL BREAST CANCER, 2016, 16 (02) : 82 - 86
  • [30] Biomodulation of capecitabine by weekly paclitaxel and carboplatin in patients with advanced solid tumor malignancies: A dose-escalating phase I study
    Lustberg, M. B.
    Nuovo, J.
    Thomas, J. P.
    Monk, P. J., III
    Kim, S.
    Villalona-Calero, M.
    Bekaii-Saab, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345